Eltromag 25 Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltromag 25 Tablet is also used to treat severe aplastic anemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anemia is a condition in which the bone marrow doesn't make enough blood cells.

Eltromag 25 Tablet contains Eltrombopag, which belongs to the class of 'thrombopoietin receptor agonists. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Eltromag 25 Tablet works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltromag 25 Tablet helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.

Take Eltromag 25 Tablet as prescribed by your doctor. In some cases, Eltromag 25 Tablet can cause common side effects like nausea, diarrhea, headache, muscle pain, tiredness, loss of appetite, fever, anemia (lack of blood cells), cough, and tingling numbness. These side effects are not familiar to everyone who takes Eltromag 25 Tablet and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you have any allergic reactions to Eltromag 25 Tablet or any other medicines before starting Eltromag 25 Tablet. It is essential to inform your doctor if you have any heart, kidney, or liver problems, blood disorders, blood clotting problems, or cataracts before starting Eltromag 25 Tablet. Consult the doctor if you are pregnant or planning to conceive. Eltromag 25 Tablet is not indicated for use in breastfeeding since it passes into the breast milk. Eltromag 25 Tablet may make you dizzy hence, drive or operate machinery only when you are mentally alert.

Measure the exact prescribed amount of Eltromag 25 Tablet. Mix Eltromag 25 Tablet with cool or cold water and administer it orally immediately after mixing.

Eltromag 25 Tablet contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA). Eltromag 25 Tablet works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus, Eltromag 25 Tablet prevents bleeding episodes by increasing the number of platelets in the blood.

If you are known to be allergic to Eltromag 25 Tablet or other medicines, please inform your doctor in advance. Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Eltromag 25 Tablet. Take Eltromag 25 Tablet at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltromag 25 Tablet. It is not recommended during pregnancy since it may have harmful effects on the foetus. Consult your doctor before using Eltromag 25 Tablet if you are a breastfeeding mother. Do not drive or operate machinery since Eltromag 25 Tablet may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive. Avoid or limit alcohol consumption with Eltromag 25 Tablet as it may affect the efficacy of Eltromag 25 Tablet. It is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.